Mangoceuticals Inc
Research Mangoceuticals Inc (MGRX) on Bullrun: market cap USD 6.66M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMGRX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyUSD
- Market capUSD 6.66M
- Financial periodQ1 2026
- RevenueUSD 67.86K
- Net income-USD 3.40M
- Free cash flow-USD 1.31M
- Gross margin42.7%
Valuation Snapshot
latest market cap is USD 6.66M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 456.02K | -USD 20.64M | -USD 5.85M | 54.9% | -2.17 | USD 1.49M | USD 307.82K | USD 15.20M |
| FY2024 | USD 615.87K | -USD 8.71M | -USD 4.86M | 61.7% | -4.8 | USD 58.65K | USD 214.96K | USD 13.95M |
| FY2023 | USD 731.49K | -USD 9.21M | -USD 7.00M | 59.0% | -8.58 | USD 739.01K | USD 128.68K | USD 774.75K |
| FY2022 | USD 8.94K | -USD 2.00M | -USD 1.39M | 54.3% | -0.19 | USD 682.86K | n/a | USD 614.03K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 6.66M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 11.76M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 7.85M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 5.94M | n/a | n/a | n/a |
About Mangoceuticals Inc
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Mangoceuticals Inc's market cap?
Mangoceuticals Inc's market capitalization is USD 6.66M.
What does Mangoceuticals Inc do?
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand.